PHIO:NASDAQ
Phio Pharmaceuticals Corp
၀.၈၇ US$
arrow_downward
-၀.၃၁%(-၀.၀၀၂၇) 1D
၀.၈၉ US$
arrow_upward
+၁.၉၁% (+၀.၀၁၇)bedtimeAfter hours
Closed: အောက် ၁၉, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PHIO...
Open
၀.၈၇ US$
High
၀.၈၉ US$
Low
၀.၈၅ US$
Mkt. cap
၁.၀၁ ကုဋေ
Avg. vol.
၁.၁၀ သိန်း
Volume
၉.၀၈ သောင်း
52-wk high
၄.၁၉ US$
52-wk low
၀.၈၁ US$
EPS
-၁.၃၉ US$
Beta
၀.၈၄
Shares outstanding
၁.၁၆ ကုဋေ
No. of employees
၆
Open
၀.၈၇ US$
High
၀.၈၉ US$
Low
၀.၈၅ US$
Mkt. cap
၁.၀၁ ကုဋေ
Avg. vol.
၁.၁၀ သိန်း
Volume
၉.၀၈ သောင်း
52-wk high
၄.၁၉ US$
52-wk low
၀.၈၁ US$
EPS
-၁.၃၉ US$
Beta
၀.၈၄
Shares outstanding
၁.၁၆ ကုဋေ
No. of employees
၆
News stories
From web sources and news partners
Pluang
·
ပြီးခဲ့သည့် ၁၁ နာရီ
Phio Pharmaceuticals to present its INTASYL siR...
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၁ နာရီ
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Profile
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
About Phio Pharmaceuticals Corp